Module 6 – Clinical Implementations of Pharmacogenomics

Modules

• Module 1 – Pharmacogenomics Primer
• Module 2 – Clinical Applications of Pharmacogenomics in Cardiology
• Module 3 – Clinical Applications of Pharmacogenomics in Psychiatry an Pain Management
• Module 4 – Education and Training in Clinical Pharmacogenomics
• Module 5 – Oncology, Adverse Drug Reactions and Electronic Health Records
• Module 6 – Clinical Implementations

Module 6 – Clinical Implementations of Pharmacogenomics

1. View the Module 6 slides and videos below

Laboratory Testing in Clinical Pharmacogenetics: How to Choose a Commercial Laboratory

Advancing Clinical Implementation of Pharmacogenetics: Progress, Needs, and Opportunities

Clinical Laboratory Testing and Reimbursement in Pharmacogenetics Overview of AMA Molecular Pathology CPT Codes and Reimbursement

Electronic and Written Documentation in Clinical Pharmacogenetics: How, When, and Why?

2. Complete the Module 6 post test, achieving a score of 13 or above. Your score will be instantly provided after you submit your exam.  If you do not achieve a score of 13 or above please contact the Office of Continuing Pharmacy Education.

3. Complete the course evaluation.

Objectives:

Laboratory Testing in Clinical Pharmacogenetics: How to Choose a Commercial Laboratory

• • • Compare and contrast approaches to clinical laboratory testing in pharmacogenomics.
    • Explain practice-based differences between panel-based testing as compared with testing individual genes for pharmacogenetic recommendations.
    • List criteria for evaluating commercial pharmacogenetic testing laboratories.
    • Identify essential information needed when interpreting commercial laboratory reports in pharmacogenetics.

Advancing Clinical Implementation of Pharmacogenetics: Progress, Needs, and Opportunities

• • • Summarize current national landscape and trends for clinical pharmacogenetics implementation in various practice settings.
    • Compare approaches to genetic testing and patient care that may be used in clinical implementation.
    • List steps for developing a new clinical pharmacogenetics patient care service.
    • Identify factors that influence the successful development of clinical pharmacogenetics services.

Clinical Laboratory Testing and Reimbursement in Pharmacogenetics

• • • Describe laboratory testing and reimbursement models for pharmacogenetic testing.
    • Compare and contrast various strategies and methods for pharmacogenetic testing and reimbursement in clinical practice.
    • Summarize reimbursement challenges in precision medicine and strategies for overcoming these challenges.
    • Determine appropriate use of CPT coding for pharmacogenetic testing.

Electronic and Written Documentation in Clinical Pharmacogenetics: How, When, and Why?

• • • Discuss the role of electronic health record in implementing clinical pharmacogenetics.
    • Summarize current initatives to improve integration of genomic data into electronic health record.
    • Identify barriers to implementing changes to the electronic health record in pharmacogenetics implementation and strategies to overcome these barriers in practice.

Speakers, Acknowledgements, and Disclosures

The following speakers have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Schedule of Activities

Review all course materials and pass post-test with 70% or more.

Requirements for Successful Course Completion

View recorded lectures, receive a 70% or higher on final exam and complete course evaluation.

Credit Reporting

• • • The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
    • All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
    • It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
    • The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.

Program Financial Support

This course received no outside funding support.

Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.

Policies

Refund Policy for CE Courses

Privacy and Confidentiality Policy

Copyright

This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

For questions or more information, please contact our office.

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.